Stock listing

NASDAQ:AXGN Axogen, Inc. Stock

Home listing (NASDAQ) of Axogen, Inc.

Follow Axogen, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:AXGN

$55.75 USD -1.20 (-2.1%)

Close on Nov 20, 2026

Past year +117.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$55.03 – $56.91 USDNov 20, 2026
Volume
875,449 sharesNov 20, 2026
Market cap
$3.33B USDAt the close on Nov 20, 2026 · price × 59.73M shares outstanding
52-week range
$25.21 – $59.72 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$71.29M USDMedian day 1.21M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Axogen, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:AXGN · Home$55.75 USD-1.20 (-2.1%)875,449$55.71$56.91$55.03$56.95Close on Nov 20, 2026
LSE:0HKD$55.97 USD-0.91 (-1.6%)586$56.16$57.07$55.00$56.88Close on Nov 20, 2026
Frankfurt:LT3€50.82 EUR-0.84 (-1.6%)—€50.44€50.82€50.44€51.66Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:AXGN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$55.75-1.20-2.1%$55.71$56.91$55.03875,449
$56.95+1.58+2.9%$55.29$57.59$55.002,113,783
$55.37-0.010.0%$55.15$56.87$54.501,352,271
$55.38-0.55-1.0%$55.56$56.35$55.001,186,265
$55.93+0.53+1.0%$55.78$57.46$55.011,380,323
$55.40-3.23-5.5%$57.75$58.30$53.873,054,877
$58.63+7.74+15.2%$50.93$59.72$50.624,412,988
$50.89+0.25+0.5%$49.70$51.10$49.231,105,728
$50.64+0.62+1.2%$50.92$51.48$49.481,297,949
$50.02+1.27+2.6%$48.55$50.29$48.141,576,372
$48.75-2.60-5.1%$51.62$51.85$47.581,210,034
$51.35+1.85+3.7%$50.28$52.75$50.081,786,466
$49.50-0.35-0.7%$50.49$50.84$49.181,037,404
$49.85+0.48+1.0%$49.46$50.54$49.041,842,470
$49.37-0.26-0.5%$49.70$49.88$48.081,833,100
$49.63+0.38+0.8%$49.61$51.16$48.392,280,900
$49.25+11.79+31.5%$45.45$49.97$43.509,288,600
$37.46-0.56-1.5%$38.14$39.04$37.232,457,800
$38.02-0.04-0.1%$38.06$38.71$37.711,021,700
$38.06+1.38+3.8%$36.64$38.33$36.602,192,100
$36.68+0.20+0.5%$36.48$37.29$36.21961,600
$36.48+0.31+0.9%$36.01$37.47$36.001,131,500
$36.17+0.93+2.6%$35.71$36.84$35.56974,400
$35.24+0.62+1.8%$34.86$35.26$34.11782,500
$34.62-1.01-2.8%$35.63$35.65$34.401,143,200
$35.63+0.49+1.4%$35.14$36.42$35.14986,000
$35.14-1.03-2.8%$35.91$36.55$35.031,172,000
$36.17-0.94-2.5%$37.20$37.40$35.832,136,600
$37.11+0.98+2.7%$36.80$37.31$35.721,606,500
$36.13-0.05-0.1%$36.35$36.80$35.60929,800
$36.18+0.14+0.4%$35.98$36.32$35.441,378,200
$36.04-0.27-0.7%$36.31$36.88$35.831,602,400
$36.31-0.91-2.4%$37.23$37.61$35.822,354,700
$37.22-0.17-0.5%$37.47$38.27$36.792,186,500
$37.39-2.53-6.3%$39.92$39.92$36.973,098,400
$39.92-2.00-4.8%$41.56$42.20$39.681,600,600
$41.92-0.52-1.2%$42.35$43.09$41.751,089,100
$42.44-0.92-2.1%$43.67$43.79$41.761,407,700
$43.36-0.03-0.1%$43.23$43.94$42.46885,500
$43.39+0.07+0.2%$43.61$44.68$43.051,221,900
$43.320.000.0%$43.18$43.95$42.55796,600
$43.32-1.22-2.7%$44.54$44.84$43.251,247,100
$44.54-1.39-3.0%$46.17$47.00$44.001,331,500
$45.93+1.70+3.8%$44.82$46.58$44.321,199,800
$44.23-1.06-2.3%$44.94$45.66$44.161,124,500
$45.29-0.15-0.3%$45.91$46.89$45.07831,400
$45.44+0.47+1.0%$44.87$46.35$44.031,423,700
$44.97+1.19+2.7%$43.85$45.46$43.511,397,000
$43.78+1.62+3.8%$41.55$44.00$41.551,668,200
$42.16+0.31+0.7%$42.48$42.59$39.623,477,600
$41.85-5.42-11.5%$45.14$45.50$41.743,793,200
$47.27+0.58+1.2%$46.21$48.11$46.00728,800
$46.69-1.59-3.3%$47.19$47.98$46.26541,500
$48.28+1.18+2.5%$46.73$48.39$46.29550,100
$47.10-1.20-2.5%$48.66$49.06$46.79951,200
$48.30-1.58-3.2%$50.15$51.50$47.83789,700
$49.88-0.88-1.7%$50.64$51.00$49.29596,600
$50.76-0.71-1.4%$50.97$51.18$49.63878,100
$51.47-0.26-0.5%$51.55$52.43$50.94771,200
$51.73+0.15+0.3%$51.88$52.91$51.16951,500
$51.58+1.65+3.3%$50.04$51.99$49.25847,600
$49.93+0.70+1.4%$49.68$50.00$48.76537,300
$49.23-1.17-2.3%$50.88$50.88$48.74704,100
$50.40+3.96+8.5%$46.50$51.06$46.241,779,700
$46.44-2.49-5.1%$48.45$49.18$45.261,033,700

Splits

1 split · NASDAQ:AXGN · every price before a split is adjusted for it

DayRatioWhat
21-for-20Split
Ticker
NASDAQ:AXGN
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Axogen, Inc. news

Axogen, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
21 in the last 12 months · 155 in all · newest Nov 3, 2026 · oldest 2019
Calls
27 calls with a replay · 27 with a transcript · latest Oct 28, 2026
Decks
36 decks · latest Nov 9, 2026

Where Axogen, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:AXGN · Home listing · This pageNASDAQUnited StatesUSD
BOATS:AXGNBOATSUnited StatesUSD
Lang & Schwarz:A1JMHKLang & SchwarzGermanyEUR
LSE:0HKDLSEUnited KingdomUSD
Frankfurt:LT3FrankfurtGermanyEUR
Tradegate:LT3TradegateGermanyEUR
Stuttgart:LT3StuttgartGermanyEUR
BMV:AXGNBMVMexicoMXN

Valuation

EV/sales 11.2× against a median of 3.6×: 9th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$2.98B USD
P/E
Loss
EV/sales
11.2×
EV/EBITDA
Negative EBITDA
Price/book
6.7×
Gross margin
74.2%
Operating margin
−5.2%
Net margin
−12.0%
Debt to equity
0.0×
Beta vs S&P 500
0.98

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Axogen, Inc. · NASDAQ:AXGNUS$3.33BUS$2.98Bn/a11.2×n/a6.7×−12.0%0.0×0.98
IMEIK Technology Development Co., Ltd. Class A · SZSE:300896US$3.67BUS$3.13B24.8×9.0×n/a3.1×42.4%0.0×n/a
Envista Holdings Corporation · NYSE:NVSTUS$3.67BUS$3.94B5.8×1.4×4.7×1.2×22.0%0.5×1.18
Shandong Weigao Blood Purification Products Co., Ltd. Class A · SSE:603014US$3.53BUS$2.97B23.4×3.7×n/a2.2×18.6%0.0×n/a
Pulse Biosciences, Inc · NASDAQ:PLSEUS$3.35BUS$3.17Bn/a2,120×n/a18.3×n/a0.0×1.54
Zhende Medical Co., Ltd. Class A · SSE:603301US$3.23BUS$3.13B73.1×4.5×n/a3.8×6.3%0.1×n/a
Lepu Medical Technology (Beijing) Co., Ltd. Class A · SZSE:300003US$3.09BUS$3.03B31.4×3.3×n/a1.3×10.7%0.2×n/a
Carl Zeiss Meditec AG · XETR:AFXUS$3.06BUS$3.06B23.9×1.1×n/a1.3×4.4%0.0×n/a
Imricor Medical Systems, Inc. · ASX:IMRUS$2.99BUS$2.96Bn/a9,790×n/a103×n/a1.2×n/a
TransMedics Group, Inc. · NASDAQ:TMDXUS$2.96BUS$2.52B20.5×3.5×19.8×5.4×19.9%0.1×1.31
Ambu A/S Class B · OMXCOP:AMBU_BUS$2.92BUS$2.92B30.9×3.1×15.9×3.2×9.9%0.1×n/a
Median of the othersUS$3.16BUS$3.04B24.4×3.6×15.9×3.2×14.6%0.1×1.31

Forecasts

9 strong buy · 2 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
59.27 USD · Analysts' mean
EPS, year to Dec 2026
0.55 · 9 analysts
Revenue, year to Dec 2026
290.4M · 10 analysts

Team and board

Officers

OfficerRole
Michael DalePresident, Chief Executive Officer and Board Director
Lindsey HartleyChief Financial Officer
Marc BeganExecutive Vice President and General Counsel
Doris QuackenbushChief Revenue Officer
Erick DeVinneyChief Scientific Officer
Ivica DucicChief Medical Officer
Jens Schroeder KempChief Marketing Officer

Board

DirectorRole
Paul G. ThomasChairman of the Board
Alan M. LevineDirector
Amy WendellDirector
John H. JohnsonDirector
Joseph TyndallDirector
Kathy WeilerDirector
Michael DalePresident, Chief Executive Officer and Board Director
William BurkeDirector

Events

Calls

CallWhenStatus
Axogen (NASDAQ:AXGN) Q3 2026 Earnings CallWed, Oct 28, 2026 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q2 2026 Earnings CallWed, Jul 29, 2026 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q1 2026 Earnings CallTue, Apr 28, 2026 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q4 2025 Earnings CallTue, Feb 24, 2026 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q3 2025 Earnings CallWed, Oct 29, 2025 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q2 2025 Earnings CallTue, Aug 05, 2025 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q1 2025 Earnings CallThu, May 08, 2025 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q4 2024 Earnings CallTue, Feb 25, 2025 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q3 2024 Earnings CallThu, Nov 07, 2024 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q2 2024 Earnings CallThu, Aug 08, 2024 · 8:00 AM ETReplay
All 27 calls
CallWhenStatus
Axogen (NASDAQ:AXGN) Q1 2024 Earnings CallThu, May 02, 2024 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q4 2023 Earnings CallTue, Mar 05, 2024 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q2 2023 Earnings CallMon, Aug 07, 2023 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q1 2023 Earnings CallTue, May 09, 2023 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q4 2022 Earnings CallTue, Mar 14, 2023 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q3 2022 Earnings CallTue, Nov 08, 2022 · 8:00 AM ETReplay
Axogen (NASDAQ:AXGN) Q2 2022 Earnings CallWed, Aug 03, 2022 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q1 2022 Earnings CallWed, May 04, 2022 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q4 2021 Earnings CallTue, Feb 22, 2022 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q3 2021 Earnings CallWed, Nov 03, 2021 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q2 2021 Earnings CallWed, Aug 04, 2021 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q1 2021 Earnings CallWed, May 05, 2021 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q4 2020 Earnings CallMon, Feb 22, 2021 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q3 2020 Earnings CallThu, Oct 29, 2020 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q2 2020 Earnings CallWed, Aug 05, 2020 · 4:30 PM ETReplay
Axogen (NASDAQ:AXGN) Q1 2020 Earnings CallWed, May 06, 2020 · 4:30 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 28, 2026 · Before open+31.5%
Q2 2026Jul 29, 2026 · Before open+0.5%
Q1 2026Apr 28, 2026 · Before open+6.6%
Q4 2025Mar 3, 2026−4.7%
Q3 2025Oct 29, 2025 · Before open+23.1%
Q2 2025Aug 5, 2025 · Before open+9.3%
Q1 2025May 8, 2025 · Before open−23.2%
Q4 2024Feb 25, 2025+8.1%
Q3 2024Nov 7, 2024 · Before open−13.4%
Q2 2024Aug 8, 2024 · Before open+35.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 2, 2024 · Before open−10.4%
Q4 2023Mar 5, 2024 · Before open−15.1%
Q3 2023Nov 7, 2023 · Before open+36.9%
Q2 2023Aug 7, 2023 · After close−19.4%
Q1 2023May 9, 2023 · Before open−3.5%
Q4 2022Mar 14, 2023 · Before open+11.9%
Q3 2022Nov 8, 2022 · Before open+12.9%
Q2 2022Aug 3, 2022 · After close+0.3%
Q1 2022May 4, 2022 · After close+18.3%
Q4 2021Feb 22, 2022 · After close+9.9%

Open Events

Decks

DeckKindSlidesDate
Investor Day (November 2026)Investor day18 slidesNov 9, 2026
Q3 2026 Earnings PresentationEarnings24 slidesOct 28, 2026
Q3 2026 Earnings PresentationEarnings26 slidesOctober 2026
Merger or Acquisition (September 2026)Merger or acquisition15 slidesSep 10, 2026
Investor Presentation (September 2026)Investor deck16 slidesSep 10, 2026
Q2 2026 Earnings PresentationEarnings23 slidesJul 29, 2026
Q2 2026 Earnings PresentationEarnings26 slidesJuly 2026
Investor Presentation (April 2026)Investor deck26 slidesApr 28, 2026
Q1 2026 Earnings PresentationEarnings21 slidesApr 28, 2026
Q4 2025 Earnings PresentationEarnings18 slidesFeb 24, 2026
All 36 decks
DeckKindSlidesDate
Investor Presentation (January 2026)Investor deck27 slidesJan 12, 2026
Q3 2025 Earnings PresentationEarnings18 slidesOct 29, 2025
Q2 2025 Earnings PresentationEarnings18 slidesAug 5, 2025
Investor Day (March 2025)Investor day73 slidesMar 4, 2025
Investor Presentation (February 2025)Investor deck46 slidesFeb 25, 2025
Q3 2024 Earnings PresentationEarnings51 slidesNov 7, 2024
Q2 2024 Earnings PresentationEarnings52 slidesAug 8, 2024
Q1 2024 Earnings PresentationEarnings50 slidesMay 2, 2024
Investor Presentation (March 2024)Investor deck51 slidesMar 5, 2024
Investor Presentation (January 2024)Investor deck54 slidesJan 8, 2024
Investor Presentation (November 2023)Investor deck54 slidesNov 7, 2023
Investor Presentation (August 2023)Investor deck56 slidesAug 7, 2023
Investor Presentation (January 2023)Investor deck47 slidesJan 9, 2023
Q3 2022 Earnings PresentationEarnings45 slidesNov 8, 2022
Q2 2022 Earnings PresentationEarnings44 slidesAug 3, 2022
Investor Presentation (May 2022)Investor deck44 slidesMay 4, 2022
FY2021 Earnings PresentationEarnings42 slidesFeb 22, 2022
Q3 2021 Earnings PresentationEarnings44 slidesNov 3, 2021
Q2 2021 Earnings PresentationEarnings44 slidesAug 4, 2021
Q1 2021 Earnings PresentationEarnings44 slidesMay 5, 2021
Q4 2020 Earnings PresentationEarnings41 slidesFeb 22, 2021
Investor Presentation (January 2021)Investor deck38 slidesJan 11, 2021
Investor Presentation (January 2020)Investor deck39 slidesJan 13, 2020
Investor Day (November 2017)Investor day22 slidesNov 21, 2017
Investor Presentation (November 2012)Investor deck27 slidesNovember 2012
Shareholder Meeting (August 2012)Shareholder meeting22 slidesAug 30, 2012

Open Decks

Financings

RaiseDate
Public offering of common stock
Made bigger: about US$124M · US$31 a share · Wells Fargo Securities +3
Dealers: Wells Fargo Securities (lead), Mizuho (lead), Canaccord Genuity, Raymond James
Use of proceeds: Early payoff and termination of its Oberland Capital term loan facility, working capital, capital expenditures and general corporate purposes
Jan 22, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue225.2M187.3M159.0M138.6M127.4M112.3M106.7M83.9M60.4M41.1M
Cost of revenue57.9M45.4M37.1M29.8M22.9M21.6M17.3M12.9M9.31M6.47M
Gross profit167.4M142.0M121.9M108.8M104.4M90.7M89.4M71.0M51.1M34.6M
Research and development32.9M27.8M27.3M25.6M24.2M17.8M17.5M11.8M6.70M4.21M
Operating income-7.85M-3.29M-21.5M-29.7M-25.4M-23.2M-31.4M-20.5M-7.95M-8.13M
Depreciation and amortization6.66M6.47M4.22M2.83M2.74M1.53M933.0K774.0K488.0K362.0K
EBITDA-1.19M3.18M-17.2M-26.9M-22.7M-21.7M-30.5M-19.7M-7.46M-7.77M
Interest expense7.70M8.21M2.83M624.0K1.36M1.05M40.0K1.21M2.22M5.39M
Income tax0000000000
Net income-15.7M-9.96M-21.7M-28.9M-27.0M-23.8M-29.1M-22.4M-10.4M-14.4M
Earnings per share, basic-0.34-0.23-0.51-0.69-0.65-0.60-0.74-0.60-0.31-0.47
Earnings per share, diluted-0.34-0.23-0.51-0.69-0.65-0.60-0.74-0.60-0.31-0.47

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents35.5M27.6M31.0M15.3M32.8M48.8M35.7M24.3M36.5M30.0M
Short-term investments5.98M5.93M033.5M51.3M55.2M60.8M92.3M
Receivables26.2M24.1M25.1M22.2M18.2M17.6M16.9M15.3M11.1M8.05M
Inventory42.4M33.2M23.0M18.9M16.7M12.5M13.9M12.0M7.32M5.46M
Current assets120.4M99.2M88.0M98.1M127.0M145.3M135.0M151.0M55.7M44.0M
Property, plant and equipment62.9M38.4M14.9M8.04M2.20M1.49M
Total assets221.7M203.7M196.8M195.4M208.0M201.4M154.6M160.2M58.9M46.4M
Accounts payable2.89M8.01M11.8M8.96M5.92M4.60M8.26M4.52M3.24M3.61M
Current liabilities23.6M30.6M30.4M23.8M24.3M22.8M20.9M13.0M13.7M11.1M
Long-term debt48.4M47.5M46.6M45.7M44.8M32.0M035.0K19.8M20.3M
Total debt48.4M47.5M46.6M45.7M44.8M32.0M063.0K20.5M20.3M
Total liabilities92.8M99.8M101.2M94.4M95.5M78.2M22.5M13.2M33.7M31.4M
Shareholders' equity128.8M103.9M95.7M101.0M112.5M123.1M132.2M147.0M25.2M14.9M
Shares outstanding47.2M44.1M43.1M42.4M41.7M40.6M39.6M38.9M34.4M33.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations812.0K4.54M-5.72M-16.1M-13.4M-9.63M-19.9M-17.9M-9.24M-11.2M
Capital spending-3.75M-3.10M-13.9M-20.1M-27.8M-21.9M-4.66M-6.28M-1.10M-931.0K
Free cash flow-2.93M1.43M-19.6M-36.1M-41.2M-31.5M-24.5M-24.1M-10.3M-12.2M
Cash from investing-5.32M-10.3M19.3M-3.20M-23.6M-17.0M27.3M-98.2M-1.29M-1.16M
Cash from financing10.5M2.29M1.95M1.79M20.5M40.5M4.03M109.8M17.0M16.5M
Change in cash5.99M-3.47M15.5M-17.5M-16.6M13.9M11.4M-6.21M6.49M4.11M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
8-K · Current reportNov 9, 2026Current reportSEC
10-Q · Quarterly reportOct 28, 2026Quarterly reportSEC
8-K · Current reportOct 28, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeOct 2, 2026Big-stake noticeSEC
8-K · Current reportOct 1, 2026Current reportSEC
424B5 · ProspectusSep 10, 2026Offer documentSEC
8-K/A · Current report, amendedSep 10, 2026Material contractSEC
8-K · Current reportSep 10, 2026Material contractSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
144 · Notice of proposed saleAug 11, 2026Other filingsSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
144 · Notice of proposed saleAug 10, 2026Other filingsSEC
144 · Notice of proposed saleAug 7, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 31, 2026Big-stake noticeSEC
10-Q · Quarterly reportJul 29, 2026Quarterly reportSEC
8-K · Current reportJul 29, 2026ResultsSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
8-K · Current reportJun 23, 2026Meeting outcomeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
144 · Notice of proposed saleMay 8, 2026Other filingsSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 8, 2026Insider tradeSEC
144 · Notice of proposed saleMay 7, 2026Other filingsSEC
144 · Notice of proposed saleMay 7, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 7, 2026Big-stake noticeSEC
144 · Notice of proposed saleMay 7, 2026Other filingsSEC
144 · Notice of proposed saleMay 7, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
10-Q · Quarterly reportApr 28, 2026Quarterly reportSEC
8-K · Current reportApr 28, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
10-K · Annual reportFeb 24, 2026Annual reportSEC
8-K · Current reportFeb 24, 2026ResultsSEC
8-K · Current reportJan 23, 2026Material contractSEC
424B5 · ProspectusJan 23, 2026Offer documentSEC
424B5 · ProspectusJan 21, 2026Offer documentSEC
S-3ASR · Registration statementJan 21, 2026Offer documentSEC
8-K · Current reportJan 12, 2026ResultsSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
144 · Notice of proposed saleDec 16, 2025Other filingsSEC
144 · Notice of proposed saleDec 16, 2025Other filingsSEC
144 · Notice of proposed saleDec 15, 2025Other filingsSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
144 · Notice of proposed saleDec 10, 2025Other filingsSEC
144 · Notice of proposed saleDec 9, 2025Other filingsSEC
144 · Notice of proposed saleDec 9, 2025Other filingsSEC
144 · Notice of proposed saleDec 9, 2025Other filingsSEC
144 · Notice of proposed saleDec 8, 2025Other filingsSEC
144 · Notice of proposed saleDec 8, 2025Other filingsSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
8-K · Current reportDec 5, 2025Management or board changeSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
8-K · Current reportDec 3, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 10, 2025Other filingsSEC
4 · Change in ownershipNov 7, 2025Insider tradeSEC
144 · Notice of proposed saleNov 6, 2025Other filingsSEC
144 · Notice of proposed saleNov 5, 2025Other filingsSEC
4 · Change in ownershipOct 31, 2025Insider tradeSEC
144 · Notice of proposed saleOct 30, 2025Other filingsSEC
144 · Notice of proposed saleOct 29, 2025Other filingsSEC
10-Q · Quarterly reportOct 29, 2025Quarterly reportSEC
8-K · Current reportOct 29, 2025ResultsSEC
4 · Change in ownershipOct 24, 2025Insider tradeSEC
144 · Notice of proposed saleOct 22, 2025Other filingsSEC
4 · Change in ownershipOct 7, 2025Insider tradeSEC
4 · Change in ownershipOct 6, 2025Insider tradeSEC
144 · Notice of proposed saleOct 6, 2025Other filingsSEC
144 · Notice of proposed saleOct 3, 2025Other filingsSEC
144 · Notice of proposed saleOct 3, 2025Other filingsSEC
144 · Notice of proposed saleOct 2, 2025Other filingsSEC
144 · Notice of proposed saleOct 2, 2025Other filingsSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
8-K · Current reportAug 25, 2025Current reportSEC
S-8 · Registration statement for employee plansAug 5, 2025Offer documentSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 5, 2025ResultsSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
8-K · Current reportJun 20, 2025Meeting outcomeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
4 · Change in ownershipJun 11, 2025Insider tradeSEC
144 · Notice of proposed saleJun 10, 2025Other filingsSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
144 · Notice of proposed saleMay 22, 2025Other filingsSEC
3 · Initial statement of ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 2, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersApr 30, 2025Annual reportSEC
DEF 14A · Proxy statementApr 30, 2025Meeting noticeSEC
8-K · Current reportApr 7, 2025Current reportSEC
4 · Change in ownershipMar 26, 2025Insider tradeSEC
4 · Change in ownershipMar 26, 2025Insider tradeSEC
4 · Change in ownershipMar 26, 2025Insider tradeSEC
4 · Change in ownershipMar 26, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
8-K · Current reportMar 4, 2025Current reportSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
10-K · Annual reportFeb 26, 2025Annual reportSEC
8-K · Current reportFeb 25, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 3, 2025Big-stake noticeSEC
144 · Notice of proposed saleJan 21, 2025Other filingsSEC
144 · Notice of proposed saleJan 14, 2025Other filingsSEC
8-K · Current reportJan 10, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 8, 2025Big-stake noticeSEC
5 · Annual statement of ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 7, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
144 · Notice of proposed saleNov 7, 2024Other filingsSEC
8-K · Current reportNov 7, 2024ResultsSEC
4 · Change in ownershipSep 17, 2024Insider tradeSEC
4 · Change in ownershipSep 13, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedSep 10, 2024Big-stake noticeSEC
8-K · Current reportSep 6, 2024Current reportSEC
144 · Notice of proposed saleSep 5, 2024Other filingsSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
144 · Notice of proposed saleAug 21, 2024Other filingsSEC
144 · Notice of proposed saleAug 13, 2024Other filingsSEC
144 · Notice of proposed saleAug 12, 2024Other filingsSEC
S-8 · Registration statement for employee plansAug 9, 2024Offer documentSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 9, 2024Insider tradeSEC

This page holds 200 of 1,001 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Axogen, Inc.’s releases · as of Oct 26, 2026

Common shares
59,730,715
Fully diluted
59,730,715

Fully diluted

LineSharesAs of
Common shares59,730,715Oct 26, 2026

Share count over time

CountShares
Oct 26, 202659,730,715

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BlackRock4.58M7.7%US$192MSep 30, 2026
First Light Asset Management, LLC3.74M6.3%US$157MSep 30, 2026
Vanguard3.52M5.9%US$147MSep 30, 2026
Fidelity2.64M4.4%US$111MSep 30, 2026
Divisadero Street Capital Management, LP2.5M4.2%US$105MSep 30, 2026
Hood River Capital Management LLC2.35M3.9%US$98.3MSep 30, 2026
Wellington1.84M3.1%US$77MSep 30, 2026
Polar Capital Holdings Plc1.81M3.0%US$75.8MSep 30, 2026
Morgan Stanley1.79M3.0%US$75MSep 30, 2026
Artemis Investment Management LLP1.78M3.0%US$74.7MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Rtw Investments, LP1.66M2.8%US$69.6MSep 30, 2026
Geode Capital1.65M2.8%US$69.2MSep 30, 2026
State Street1.28M2.1%US$53.7MSep 30, 2026
T. Rowe Price1.24M2.1%US$51.8MSep 30, 2026
Stephens Investment Management Group LLC1.13M1.9%US$47.4MSep 30, 2026
Wasatch Advisors LP1.12M1.9%US$47MSep 30, 2026
Soleus Capital Management, L.P.1.08M1.8%US$45.3MSep 30, 2026
Bamco Inc855K1.4%US$35.8MSep 30, 2026
Next Century Growth Investors LLC844K1.4%US$35.4MSep 30, 2026
Goldman Sachs746K1.2%US$31.3MSep 30, 2026
TimesSquare Capital Management, LLC727K1.2%US$30.5MSep 30, 2026
Driehaus Capital Management LLC696K1.2%US$29.2MSep 30, 2026
Armistice Capital, LLC692K1.2%US$29MSep 30, 2026
DWS653K1.1%US$27.4MSep 30, 2026
Bessemer Group Inc576K0.96%US$24.1MSep 30, 2026
Holocene Advisors, LP557K0.93%US$23.3MSep 30, 2026
Dimensional539K0.90%US$22.6MSep 30, 2026
Alyeska Investment Group, L.P.520K0.87%US$21.8MSep 30, 2026
Schwab510K0.85%US$21.4MSep 30, 2026
Northern Trust494K0.83%US$20.7MSep 30, 2026
ArrowMark Colorado Holdings LLC492K0.82%US$20.6MSep 30, 2026
NZS Capital, LLC463K0.77%US$19.4MSep 30, 2026
Nomura458K0.77%US$19.2MSep 30, 2026
Arrowstreet Capital, Limited Partnership449K0.75%US$18.8MSep 30, 2026
Fred Alger Management, LLC442K0.74%US$18.5MSep 30, 2026
Assenagon Asset Management S.A.412K0.69%US$17.3MSep 30, 2026
AllianceBernstein402K0.67%US$16.8MSep 30, 2026
Point72 Asset Management, L.P.394K0.66%US$16.5MSep 30, 2026
ExodusPoint Capital Management, LP363K0.61%US$15.2MSep 30, 2026
Nuveen354K0.59%US$14.8MSep 30, 2026
Capricorn Fund Managers Ltd353K0.59%US$14.8MSep 30, 2026
UBS351K0.59%US$14.7MSep 30, 2026
HighMark Wealth Management LLC342K0.57%US$14.4MSep 30, 2026
Jacobs Levy Equity Management, Inc338K0.57%US$14.2MSep 30, 2026
Russell Investments Group, Ltd.335K0.56%US$14MSep 30, 2026
Oberweis Asset Management Inc/326K0.55%US$13.7MSep 30, 2026
Bank of America324K0.54%US$13.6MSep 30, 2026
First Eagle Investment Management, LLC319K0.53%US$13.4MSep 30, 2026
Raymond James Financial Inc313K0.52%US$13.1MSep 30, 2026
Wcm Investment Management, LLC313K0.52%US$13.3MSep 30, 2026

This page holds 50 of 245 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.6M2.7%US$73.7MJun 30, 2026
iShares Russell 2000 ETF1.37M2.3%US$63.5MJun 30, 2026
Hood River Small-Cap Growth Fund688K1.2%US$31.8MJun 30, 2026
Vanguard Extended Market Index Fund610K1.0%US$28.2MJun 30, 2026
T. Rowe Price New Horizons Fund, Inc.588K0.98%US$27.2MJun 30, 2026
Fidelity Small Cap Index Fund575K0.96%US$24.3MJul 31, 2026
Baron Discovery Fund533K0.89%US$24.6MJun 30, 2026
Fidelity Stock Selector Small Cap Fund526K0.88%US$22.2MJul 31, 2026
iShares Russell 2000 Growth ETF486K0.81%US$22.4MJun 30, 2026
Vanguard Explorer Fund428K0.72%US$18.1MJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Oberweis Micro-Cap Fund375K0.63%US$17.3MJun 30, 2026
Wasatch Small Cap Growth Fund310K0.52%US$14.3MJun 30, 2026
Nomura Small Cap Growth Fund308K0.52%US$14.2MJun 30, 2026
Fidelity Series Small Cap Opportunities Fund302K0.51%US$12.7MJul 31, 2026
First Eagle Small Cap Opportunity Fund300K0.50%US$12.7MJul 31, 2026
Wasatch Micro Cap Fund294K0.49%US$13.6MJun 30, 2026
Alger Small Cap Focus Fund291K0.49%US$12.3MJul 31, 2026
Meridian Growth Fund285K0.48%US$13.2MJun 30, 2026
Old Westbury Small & Mid Cap Strategies Fund280K0.47%US$11.8MJul 31, 2026
Nuveen Quant Small Cap Equity Fund269K0.45%US$11.3MJul 31, 2026
Fidelity Enhanced Small Cap Core ETF265K0.44%US$12.2MJun 30, 2026
Fidelity Extended Market Index Fund259K0.43%US$10.2MMay 31, 2026
iShares U.S. Medical Devices ETF249K0.42%US$11.5MJun 30, 2026
Vanguard Russell 2000 Index Fund248K0.42%US$9.8MMay 31, 2026
Schwab U.S. Small-Cap ETF241K0.40%US$9.51MMay 31, 2026
JNL Multi-Manager Small Cap Growth Fund237K0.40%US$10.9MJun 30, 2026
Calamos Timpani Small Cap Growth Fund229K0.38%US$9.67MJul 31, 2026
Wasatch Micro Cap Value Fund191K0.32%US$8.83MJun 30, 2026
Meridian Small Cap Growth Fund188K0.32%US$8.7MJun 30, 2026
Brown Capital Management Small Company Fund180K0.30%US$8.32MJun 30, 2026
AST Small-Cap Equity Portfolio155K0.26%US$7.16MJun 30, 2026
Fidelity SAI Small-Mid Cap Momentum Index Fund153K0.26%US$6.46MJul 31, 2026
First Trust Small Cap Growth AlphaDEX Fund152K0.25%US$6.42MJul 31, 2026
Dimensional U.S. Small Cap ETF148K0.25%US$6.24MJul 31, 2026
Vanguard Health Care Index Fund138K0.23%US$5.45MMay 31, 2026
Schwab Small-Cap Index Fund128K0.21%US$5.41MJul 31, 2026
U.S. Micro Cap Portfolio128K0.21%US$5.39MJul 31, 2026
Invesco Dorsey Wright Healthcare Momentum ETF115K0.19%US$4.84MJul 31, 2026
Driehaus Micro Cap Growth Fund111K0.19%US$5.14MJun 30, 2026
VictoryShares US Small Mid Cap Value Momentum ETF96,0140.16%US$4.43MJun 30, 2026
Master Small Cap Index Series95,7820.16%US$4.42MJun 30, 2026
Fidelity Total Market Index Fund94,7750.16%US$3.74MMay 31, 2026
College Retirement Equities Fund - Total Global Stock Account84,0500.14%US$3.88MJun 30, 2026
Goldman Sachs Small Cap Equity Insights Fund83,9210.14%US$3.54MJul 31, 2026
Principal U.S. Small-Cap ETF83,4610.14%US$3.86MJun 30, 2026
Fidelity Series Total Market Index Fund76,9790.13%US$3.04MMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF72,6490.12%US$3.36MJun 30, 2026
American Beacon Stephens Small Cap Growth Fund71,5690.12%US$3.31MJun 30, 2026
U.S. Small Cap Portfolio69,7610.12%US$2.94MJul 31, 2026
Nuveen Small Cap Blend Index Fund66,8080.11%US$2.82MJul 31, 2026

This page holds 50 of 239 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Tyndall Joseph A.
Director
Sale3,500USD 49.70US$174KSep 2, 2026
Wendell Amy McBride
Director
Sale13,353USD 48.42US$647KAug 11, 2026
Began Marc A
Officer: EVP & General Counsel
Sale67,500USD 47.35US$3.2MAug 10, 2026
Weiler Kathy Johnson
Director
Sale14,150USD 45.30US$641KAug 7, 2026
Wendell Amy McBride
Director
Sale1,647USD 42.60US$70,162May 8, 2026
Quackenbush Doris
Officer: Sales VP
Sale3,878USD 43.51US$169KMay 7, 2026
Hartley Lindsey Marie
Officer: CFO
Sale478USD 43.67US$20,874May 7, 2026
Hartley Lindsey Marie
Officer: CFO
Sale573USD 43.67US$25,023May 7, 2026
Kemp Jens
Officer: Chief Marketing Officer
Sale4,000USD 43.44US$174KMay 7, 2026
Weiler Kathy Johnson
Director
Sale16,344USD 44.09US$721KMay 7, 2026
All 11 trades
TradeTradeSharesPriceValueDate
Johnson John
Director
Sale11,050USD 43.26US$478KMay 7, 2026

Big stakes

StakeStakeSharesDateFiling
First Light Asset Management, LLC7.58%4.07MJun 30, 2026Schedule 13G
Divisadero Street Capital Management, LP6.80%3.98MOct 2, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John H. Johnson
Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); AVEO Pharmaceuticals Inc (Director · Feb 1, 2018 – Feb 1, 2018 · Past); Strongbridge Biopharma plc (Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Jun 2, 2016 – Feb 13, 2018 · Past)
Director · Since at least Jul 19, 2021
Paul G. Thomas
Other companies: TELA Bio, Inc. (Director · Since at least Apr 30, 2026); Surgalign Holdings Inc (Director · Mar 8, 2019 – Aug 15, 2022 · Past); RTI Surgical Holdings Inc (Director · May 26, 2016 – Mar 8, 2019 · Past); Roka Bioscience Inc (President and CEO, Director · Jul 16, 2014 – Nov 10, 2016 · Past); Aegerion Pharmaceuticals Inc (Director · Aug 1, 2011 – Nov 29, 2016 · Past); ABIOMED Inc (Director · May 26, 2011 – Dec 22, 2022 · Past); Kinetic Concepts Inc (President, LifeCell Corp. · May 20, 2008 – Aug 25, 2008 · Past); Orthovita Inc (Director · Jul 27, 2007 – Jun 24, 2011 · Past); Avanir Pharmaceuticals Inc (Director · Feb 13, 2006 – Mar 1, 2007 · Past); Lifecell Corp (Chairman, President and CEO, Director · Jan 3, 2006 – May 19, 2008 · Past)
Chairman of the Board · Since at least Sep 30, 2020
Quentin Blackford
Other companies: Align Technology, Inc. (Director · Since at least Aug 27, 2026); iRhythm Holdings, Inc. (President, Chief Executive Officer and Director · Since at least Oct 4, 2021); Alphatec Holdings, Inc. (Director · Since at least Oct 2, 2017); Paragon 28 Inc (Director · Aug 1, 2022 – Apr 21, 2025 · Past); DexCom, Inc. (Chief Operating Officer · Sep 7, 2017 – Sep 8, 2021 · Past); NuVasive Inc (CFO · Jul 1, 2016 – Feb 8, 2017 · Past)
Director · Apr 26, 2019 – Mar 30, 2022 · Past
Guido J. Neels
Other companies: TELA Bio, Inc. (Director · Since at least Apr 30, 2026); Elutia, Inc. (Director · Since at least Oct 9, 2025); Bioventus Inc. (Director · Since at least Feb 11, 2021); Entellus Medical Inc (Director · Jun 14, 2016 – Feb 28, 2018 · Past); Endologix Inc (Director · Nov 3, 2015 – Apr 3, 2019 · Past)
Director · Since at least Aug 26, 2015
Lisa N Colleran
Other companies: TELA Bio, Inc. (Director · Since at least Apr 20, 2020); Establishment Labs Holdings Inc. (Director · Jul 18, 2018 – Jun 17, 2022 · Past); Rockwell Medical, Inc. (Director · Mar 7, 2018 – Jun 6, 2019 · Past); Kinetic Concepts Inc (Global President, LifeCell · Aug 27, 2008 – Nov 4, 2011 · Past); Lifecell Corp (SVP Commercial Operations · Jan 3, 2006 – May 19, 2008 · Past)
Director · Jul 9, 2018 – Jul 9, 2018 · Past
Amy Wendell
Other companies: Hologic Inc (Director · Since at least Feb 26, 2026); Baxter International Inc. (Director · Since at least May 6, 2025); Solventum Corporation (Director · Since at least Apr 30, 2025)
Director · Since at least Jun 9, 2025
Karen Zaderej
Other companies: EyePoint, Inc. (Board Member · Since at least Jul 11, 2022); Viveve Medical, Inc. (Director · Apr 1, 2019 – Nov 26, 2019 · Past)
CEO, Director · May 29, 2019 – Mar 16, 2024 · Past
Robert James Rudelius
Other companies: PetVivo Holdings Inc (Director · Since at least Jan 3, 2018); ProUroCare Medical Inc. (Director · Feb 28, 2008 – Sep 10, 2013 · Past)
Director · Sep 22, 2010 – Sep 30, 2020 · Past
Kathy Johnson Weiler
Other companies: American Well Corporation (Chief Comm. & Growth Officer · Jun 1, 2023 – Dec 2, 2024 · Past)
Director · Since at least Dec 20, 2023
Kathy Weiler
Other companies: Solventum Corporation (Chief Transformation and Enterprise Services Officer · Since at least Nov 4, 2026)
Director · Since at least Aug 11, 2026
All 35 people
PersonSeat
Michael Dale
Other companies: CVRx, Inc. (Chief Executive Officer and President · Since at least Apr 20, 2026)
President, Chief Executive Officer and Board Director · Since at least Oct 28, 2026
William Burke
Other companies: Miromatrix Medical Inc (Director · Dec 12, 2023 – Dec 12, 2023 · Past)
Director · Since at least Jun 6, 2024
Alan M. LevineDirector · Since at least Apr 26, 2019
Al JacksVice President of Quality · Nov 4, 2026 – Nov 4, 2026 · Past
Amalia De LucaVice President of Planning and Business Development · Nov 4, 2026 – Nov 4, 2026 · Past
Angelo ScopelianosChief R&D Officer · Sep 4, 2018 – Mar 16, 2024 · Past
Bradley OttingerGeneral Counsel and CCO · Jun 1, 2020 – Mar 16, 2023 · Past
Daniel C SiggDirector · Nov 21, 2006 – Sep 26, 2008 · Past
David K HansenVP Finance & Treasurer · Dec 28, 2015 – Aug 21, 2019 · Past
Doris QuackenbushChief Revenue Officer · Since at least May 1, 2026
Erick DeVinneyChief Scientific Officer · Since at least Dec 18, 2017
Ivica DucicChief Medical Officer · Since at least Nov 4, 2026
Jamie Mark GroomsDirector · Sep 30, 2011 – Aug 14, 2019 · Past
Jens Schroeder KempChief Marketing Officer · Since at least Jan 1, 2024
Jesse BishopVice President of Regulatory · Nov 4, 2026 – Nov 4, 2026 · Past
John P EngelsVP · Sep 30, 2011 – Jun 8, 2017 · Past
Joseph TyndallDirector · Since at least Jun 6, 2024
Kevin Christopher Worms-LynchDirector · Sep 22, 2010 – Nov 1, 2010 · Past
Lindsey HartleyChief Financial Officer · Since at least May 12, 2025
Marc BeganEVP & General Counsel · Since at least Dec 4, 2025
Mark Louis FriedmanVP Regulatory Affairs & Policy · Sep 30, 2011 – Mar 16, 2022 · Past
Paris DallyVice President, Operations · Nov 4, 2026 – Nov 4, 2026 · Past
Rick DittoVP, Global Health Economics, Reimbursement & Policy · Nov 4, 2026 – Nov 4, 2026 · Past
Stacy ArnoldVice President of Product Development and Research · Nov 4, 2026 – Nov 4, 2026 · Past
Todd GoedeVice President and General Manager, NerveTape® Operations · Nov 4, 2026 – Nov 4, 2026 · Past

Open People

Log in to ask 6ix AI your own questions about Axogen, Inc.